Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

FDA Approves Same Day 2nd Eye Laser Treatment
Jul 1999
FREMONT, Calif., July 21 -- Sunrise Technologies International, Inc. reports that it has received conditional approval from the US Food and Drug Administration to treat both patients' eyes on the same day as part of its ongoing US clinical trials of the company's laser thermal keratoplasty (LTK) treatment. LTK is used to treat mid-hyperopia, or farsightedness, from +2.75 to +4.0 diopters; the company estimates that nearly 90 percent of all hyperopes over age 40 fall under the four diopters limit.
FDA approval allows for treatment of the second eye of the current subjects as well as treatment of both eyes of future subjects on the same day. On May 4, 1999, Sunrise announced that it had received approval from the FDA to expand its study to 80 patients at up to six clinical sites in the US.

News & Featureslasers

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.